To explore the use of intensive lipid\|lowering effect of atorvastatin in patients with acute coronary syndrome,serum high\|sensitivity C\|reactive protein(hs\|CRP)the impact of ACS in order to understand their effects on inhibiting inflammation and plaque stabilityMethods:80 patients selected ACS patients were randomly divided into conventional therapy group(n=40)and the atorvastatin group(n=40)Conventional treatment group received conventional drug therapy,without lipid\|lowering drug atorvastatin group was atorvastatin 40 mg / d,orallyDrug therapy in all patients before and after treatment 7d and 30d collected blood examination hs\|CRPResults:The atorvastatin group after treatment 7d serum hs\|CRP levels were significantly lower(P＜005),whereas no significant change in the conventional groupThe conventional therapy group after 30d of serum hs\|CRP to normal levels,but lower atorvastatin group was significantly higher than the conventional therapy group level(P＜005)Conclusions:Atorvastatin could reduce inflammatory factors in serum of patients with ACS with a role in inhibiting inflammation and plaque stability.